Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • ...

    Tag: Drugs Controller General of India

    You Searched For "drugs-controller-general-of-india"
    AstraZeneca Pharma India gets DCGI nod for Calquence-Acalabrutinib 100mg capsules

    AstraZeneca Pharma India gets DCGI nod for Calquence-Acalabrutinib 100mg capsules

    Medical Dialogues Bureau14 March 2020 12:03 PM IST
    Acalabrutinib 100mg capsules are indicated for the treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).
    FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer

    FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer

    Medical Dialogues Bureau22 Nov 2019 12:25 PM IST
    "Atezolizumab is the first cancer immunotherapy to receive approval from DCGI in India for the first-line treatment of extensive-stage small-cell lung...
    Six bodies registered with CDSCO to audit medical device manufacturing sites as per new MD Rules

    Six bodies registered with CDSCO to audit medical device manufacturing sites as per new MD Rules

    Farhat Nasim4 Aug 2019 3:29 PM IST
    New Delhi: Through a recent public notice, the apex drug regulatory body, Central Drugs Standard Control Organisation(CDSCO) has notified six bodies...
    Drug Alert: CDSCO declares 31 samples as sub-standard in quality in random sampling; Details

    Drug Alert: CDSCO declares 31 samples as sub-standard in quality in random sampling; Details

    Meghna A Singhania21 May 2019 4:44 PM IST
    New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared more than a dozen drugs as sub-standard in...
    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    Meghna A Singhania3 April 2019 4:30 PM IST
    New Delhi: After facing trouble with its baby talcum powder amid allegations that it contains asbestos, US healthcare giant Johnson and Johnson (JnJ)...
    Final regulations on e pharmacy likely by December-end, says DCGI

    Final regulations on e pharmacy likely by December-end, says DCGI

    Farhat Nasim8 Dec 2018 10:29 AM IST
    In September, the Union health ministry came out with draft rules on the sale of drugs by e pharmacies. Panaji: The union government is expected to...
    Contaminated Polio Vaccines: Ghaziabad pharma firm banned by Health Ministry

    Contaminated Polio Vaccines: Ghaziabad pharma firm banned by Health Ministry

    Medical Dialogues Bureau4 Oct 2018 10:40 AM IST
    New Delhi: The Ministry of Health and Family Welfare said it has banned a Ghaziabad based pharmaceutical company after a probe traces of polio type-2...
    WHO prequalification for Rotavirus vaccine from India

    WHO prequalification for Rotavirus vaccine from India

    Medical Dialogues Bureau3 Oct 2018 5:04 PM IST
    ROTASIIL is an oral vaccine administered to infants in a three-dose course at 6, 10, and 14 weeks of age, at the same time as routine vaccinations....
    Roche plea in HC on cancer drug not maintainable: Biocon, Mylan

    Roche plea in HC on cancer drug not maintainable: Biocon, Mylan

    Ruby Khatun Khatun12 Jan 2018 10:27 AM IST
    New Delhi: Generic drug makers Biocon and Mylan told the Delhi High Court that Swiss pharma major Roche's civil suit, challenging DCGI approvals...
    Indian online pharmacy huge health risk: Pharma Body

    Indian online pharmacy huge health risk: Pharma Body

    Ruby Khatun Khatun18 Dec 2017 4:08 PM IST
    New Delhi: Indian pharmacists fear rise in self-medication and abuse unless online drug sales are checked.In the run-up to the 69th Indian...
    To market new drugs in India, global trials must include Indians

    To market new drugs in India, global trials must include Indians

    Ruby Khatun Khatun12 Oct 2017 3:21 PM IST
    New Delhi: The drug regulator in a recent technical committee meeting, headed by Jagdish Prasad, Director General of Health Services, has made it...
    Chemist prescribing OTC medicines: Drug advisory body gives in-principle approval

    Chemist prescribing OTC medicines: Drug advisory body gives in-principle approval

    Ruby Khatun Khatun25 Sept 2017 1:41 PM IST
    New Delhi: The proposal to introduce a new category of over the counter (OTC) medicines which will empower the pharmacists to dispense drugs for minor...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok